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Hippocampal volume as marker of daily life stress
sensitivity in psychosis
D. Collip#, P. Habets#, M. Marcelis, E. Gronenschild, T. Lataster, M. Lardinois, N. A. Nicolson and
I. Myin-Germeys* for G.R.O.U.P.
Department of Psychiatry and Psychology, School for Mental Health and Neuroscience, EURON, Maastricht University Medical Centre,
Maastricht, The Netherlands
Background. Reduced hippocampal size and increased stress sensitivity are associated with psychotic disorder and
familial risk for psychosis. However, to what degree the hippocampus is implicated in daily life stress reactivity has
not yet been examined. The current study investigated (i) whether familial risk (the contrast between controls,
patients and siblings of patients) moderated the relationship between hippocampal volume (HV) and emotional daily
stress reactivity and (ii) whether familial risk (the contrast between controls and siblings of patients) moderated the
relationship between HV and cortisol daily stress reactivity.
Method. T1-weighted magnetic resonance imaging (MRI) scans were acquired from 20 patients with schizophrenia,
37 healthy siblings with familial risk for schizophrenia and 32 controls. Freesurfer 5.0.0 was used to measure HV.
The experience sampling method (ESM), a structured momentary assessment technique, was used to assess emotional
stress reactivity, that is the effect of momentary stress on momentary negative affect (NA). In addition, in the control
and sibling groups, cortisol stress reactivity was assessed using momentary cortisol levels extracted from saliva.
Results. Multilevel linear regression analyses revealed a significant three-way interaction between group, HV
and momentary stress in both the model of NA and the model of cortisol. Increased emotional stress reactivity
was associated with smaller left HV in patients and larger total HV in controls. In line with the results in patients,
siblings with small HV demonstrated increased emotional and cortisol stress reactivity compared to those with
large HV.
Conclusions. HV may index risk and possibly disease-related mechanisms underlying daily life stress reactivity in
psychotic disorder.
Received 11 October 2011 ; Revised 16 August 2012 ; Accepted 23 August 2012
Key words : Cortisol, genetic predisposition to disease, hippocampus, hypothalamo-hypophyseal system, magnetic
resonance imaging, psychological stress, schizophrenia, stress.
Introduction
Patients with psychotic disorder generally display re-
duced hippocampal size (Wright et al. 2000 ; Geuze
et al. 2005 ; Steen et al. 2006 ; Vita et al. 2006). Studies
have shown that similar alterations in hippocampal
volume (HV) may be present in first-degree relatives
of patients with schizophrenia (Boos et al. 2007 ; Lawrie
et al. 2008), suggesting that HV alterations constitute
part of the liability to psychosis. The hippocampus
plays a pivotal role in regulating emotional responses
to stressful stimuli and in the negative feedback mech-
anism controlling hypothalamic–pituitary–adrenal
(HPA) axis activity (Jacobson & Sapolsky, 1991 ;
Sapolsky, 2000 ; Corcoran et al. 2003 ; Buchanan et al.
2009). Because the hippocampus has an inhibitory in-
fluence, a smaller HV might be associated with
increased HPA axis reactivity to stress. Indeed, in
clinical and aged samples, studies have reported an
inverse association between HV and cortisol levels
(Lupien et al. 1998 ; Knoops et al. 2010). Similarly,
in patients with a psychotic disorder, smaller left HV
was associated with higher salivary cortisol levels
(Mondelli et al. 2010b).
By contrast, findings in (younger) healthy volun-
teers show mixed results. One study, examining the
association between HV and cortisol response to ex-
perimental psychological stress and also to awakening
(Pruessner et al. 2010), found a positive association
between HV and cortisol reactivity in young healthy
volunteers, whereas a negative association between
HV and the cortisol response to a physiological
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challenge was found in another sample (Tessner et al.
2007). These findings indicate that the association be-
tween HV and stress reactivity may be different in
healthy and clinical populations.
Familial vulnerability for psychosis has been as-
sociated with amplified emotional and cortisol re-
sponses to stress in daily life. Patients with a psychotic
disorder and their unaffected first-degree relatives
have been found to display increased negative
emotions and an increase in psychotic experiences
(Myin-Germeys et al. 2001, 2005). A recent study
showed that siblings of patients compared to controls
responded with increased cortisol secretion to minor
everyday stressors (Collip et al. 2011). However, the
neural mechanisms underlying this augmented stress
sensitivity have not yet been identified.
In the current study we investigated whether HV is
associated with emotional and cortisol reactivity to
daily life stress, as indexed by momentary variation in
negative affect (NA) and momentary cortisol levels.
Given the reported discrepancy between clinical and
non-clinical samples in the association between HV
and cortisol (Pruessner et al. 2007), we examined
whether this association was moderated by genetic
risk for psychosis. Because some earlier studies sug-
gest that cortisol levels are primarily associated with
the left HV (Mondelli et al. 2010b), analyses also
investigated hemispheric differentiation ; that is dif-
ferences in the HV stress reactivity. Analyses thus
examined (i) to what degree HV was associated with
emotional (for patients, siblings and controls) and
cortisol (for siblings and controls) reactivity to daily
stress, (ii) whether genetic/familial risk (the contrast
between controls, patients and siblings of patients)
moderated the relationship between HV and emo-
tional daily stress reactivity and (iii) whether familial
risk (the contrast between controls and siblings of
patients) moderated the relationship between HV and
cortisol daily stress reactivity.
Method
Participants
The sample included patients with a diagnosis of
non-affective psychotic disorder, their siblings, and
controls from the general population, in the context
of the Dutch national Genetic Risk and Outcome
of Psychosis (GROUP) project (Kahn et al. 2011). In
selected representative geographical areas in The
Netherlands and Belgium, patients were identified by
clinicians whose caseload was screened for inclusion
criteria. Subsequently, a group of patients presenting
consecutively at these services, either as out-patients
or in-patients, were recruited for the study.
First-degree relatives were recruited through partici-
pating patients. Control subjects were recruited from
the same population as the patients, through random
mailings in the geographic region and advertisements
in newspapers. All interviews were conducted by
trained psychology graduates. From the wider sam-
pling frame, the following subgroups were selected:
20 patients with a diagnosis of non-affective psychotic
disorder, 37 siblings of patients with a diagnosis of
schizophrenia and 32 controls. As the sibling group
was recruited by asking the patients to inform their
brothers and sisters about the study, participants
were clustered within families. Inclusion criteria were :
(i) age between 16 and 55 years and (ii) sufficient
command of the Dutch language. Exclusion criteria
were : (i) use of steroid medication, (ii) a current Axis I
disorder, (iii) a lifetime history of psychotic disorder,
and, for the controls, (iv) a family history of psychotic
disorder as assessed by the Family Interview for
Genetic Studies (FIGS; Maxwell, 1992 ; NIMHGenetics
Initiative, 1992).
Diagnosis (lifetime) was based on DSM-IV criteria
(APA, 2000) assessed with the Comprehensive
Assessment of Symptoms and History (CASH) inter-
view (Andreasen et al. 1992). Patients were diagnosed
with : schizophrenia (n=11), schizo-affective disorder
(n=2), schizophreniform disorder (n=1), brief psy-
chotic disorder (n=2) and psychotic disorder not
otherwise specified (n=4). The CASHwas also used to
confirm the absence of a lifetime diagnosis of psy-
chotic disorder or any current affective disorder in the
siblings and in the healthy controls. Prior to magnetic
resonance imaging (MRI) acquisition, participants
were screened for the following exclusion criteria :
(i) brain injury with unconsciousness for >5 min,
(ii) meningitis or other neurological diseases that
might have affected brain structure/function, (iii) res-
piratory or cardiac disease and (iv) severe claustro-
phobia. In addition, subjects with metal corpora aliena
were excluded from the study, along with women
with an intrauterine device or (suspected) pregnancy.
To prevent interference, the MRI scan was not taken
during the week when the experience sampling
method (ESM) technique was used (discussed later).
MRI scans were conducted between several weeks and
months after ESM. The study was approved by the
standing ethics committee, and all the subjects gave
written informed consent in accordance with the
committee’s guidelines.
Measures
The Positive and Negative Syndrome Scale (PANSS;
Kay et al. 1987) was used to measure psychotic symp-
toms over the past 2 weeks.
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Antipsychotic medication (AP) was determined
from reports of the participant’s psychiatrist. Best-
estimate lifetime (cumulative) AP use was determined
by multiplying the number of days of AP use by the
corresponding haloperidol equivalents and summing
these scores for all periods of AP use (Cahn et al. 2002).
Estrogen exposure was estimated by multiplying
the number of months of oral contraceptive use by
micrograms of estrogen (of the corresponding oral
contraceptive) per month.
Substance use was assessed using the Composite
International Diagnostic Interview (CIDI) sections
B–J–L (WHO, 1990). Cannabis use and other drug
use [stimulants, sedatives, opiates, cocaine, PCP,
psychedelics, inhalants, or other (e.g. XTC, poppers)]
was assessed as reported frequency of use (i) during
the past 12 months and (ii) lifetime. Alcohol and
tobacco use was defined as the reported number of
weekly consumptions during the past 12 months.
ESM
The ESM is a random time-sampling self-assessment
technique; studies have demonstrated the feasibility,
validity and reliability of ESM in general and patient
populations (Csikszentmihalyi & Larson, 1987 ;
Myin-Germeys et al. 2009). Subjects received a digital
wristwatch that emitted a signal 10 times a day on
six consecutive days, at unpredictable moments
between 07:30 and 22:30 hours. After each ‘beep’,
subjects completed ESM self-assessment forms con-
cerning current context, thoughts, emotions and psy-
chotic experiences.
ESM measures
Event stress. In accordance with previous work, stress
was conceptualized as the subjectively appraised un-
pleasantness of distinctive events (Myin-Germeys et al.
2001). After each beep, participants were asked to re-
port the most important event that had happened
between the current and the previous report and then
to rate this event on a seven-point scale (x3=very
unpleasant, 0=neutral, 3=very pleasant). For the
current analyses, all positive responses were recoded
as 0, and the negative responses were recoded so that
high scores reflect more unpleasant and potentially
stressful events (0=neutral, 3=very unpleasant)
(Jacobs et al. 2007).
NA. In line with previous reports (Myin-Germeys et al.
2001), ESM NA was assessed as the mean score on six
ESM items, rated on seven-point Likert scales (1=not
at all to 7=very) : ‘ I feel insecure ’, ‘ I feel lonely ’, ‘ I feel
anxious’, ‘ I feel down’, ‘ I feel guilty ’ and ‘I feel
angry/ irritated ’ (Cronbach’s a=0.84).
Salivary cortisol sampling
After each ESM beep, siblings and controls collected a
saliva sample with a cotton swab (Salivette ; Sarstedt,
The Netherlands), replaced the swab in the salivette
tube and recorded the exact collection time. No saliva
was collected in the patient group because AP could
have affected cortisol levels and brain structures
(Meltzer et al. 1989 ; Wik, 1995 ; Pariante, 2008).
Samples were stored in subjects’ home freezers until
transport to the laboratory, where uncentrifuged
samples were kept at x20 xC until analysis. Saliva
samples collected more than 15 min after the beep
were excluded from the analysis.
MRI acquisition and processing
MRI scans were acquired using a 3-T Siemens
scanner and the following acquisition parameters : for
the modified driven equilibrium Fourier transform
(MDEFT) sequence : 176 slices, 1 mm isotropic voxel
size, echo time (TE) 2.4 ms, repetition time (TR)
7.92 ms, flip angle 15x, total acquisition time 12 min
51 s ; and for the magnetization prepared rapid acqui-
sition gradient echo (MP-RAGE) : Alzheimer’s Disease
Neuroimaging Initiation (ADNI) sequence : 192 slices,
1 mm isotropic voxel size, TE 2.6 ms, TR 2250 ms,
flip angle 9x, total acquisition time 7 min 23 s. For
both sequences the matrix size and field of view were
256r256. Two sequences were used because of a
scanner update during data collection. The MP-RAGE
andMDEFT sequences are very similar, but to prevent
any systematic bias, the total proportion of MP-RAGE
scans (around 1/3) was balanced between the groups
(for more detail see Habets et al. 2011).
MRI preprocessing
Scans were processed and analyzed using Freesurfer
stable release version 5.0.0. Technical details of these
procedures are described in previous publications (Dale
et al. 1999; Fischl et al. 1999, 2002; Fischl & Dale, 2000;
Segonne et al. 2004; Han et al. 2006; Jovicich et al. 2006).
Volume measures
The automated procedures for volumetric measures of
the different brain structures are described by Fischl
et al. (2002). These procedures automatically assign a
neuroanatomical label to each voxel in an MRI volume
based on probabilistic information automatically esti-
mated from a manually labeled training set.
The accurate labeling of subcortical structures
is achieved through the use of both global and local
information. The global information is based on an
atlas that makes the labeling robust to variations
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in contrast properties of the anatomical structures.
Local information is incorporated by modeling the
classification as a non-stationary anisotropic Markov
random field. The introduction of non-stationarity and
anisotropy into the classical Markov random field
model allows spatial relationships of anatomical
classes to enter into the segmentation procedure. For
instance, the probability that a voxel labeled hippo-
campus will have its inferior neighbor labeled as
amygdala provides a strong set of spatial constraints.
The training set included healthy persons in the
age range 18–87 years and a group of patients with
Alzheimer’s disease in the age range 60–87 years, and
the classification technique uses a registration pro-
cedure that is robust to anatomical variability, includ-
ing the ventricular enlargement typically associated
with neurological diseases and aging. The technique
has previously been shown to be comparable in accu-
racy to manual labeling (Fischl et al. 2004). The seg-
mentations were visually inspected for accuracy.
Statistical analyses
ESM and cortisol data were analyzed using multilevel
regression techniques, which take the hierarchical
structure of the data into account. In the current study,
repeated momentary measurements (level 1) were
nested in subjects (level 2) who were part of the same
family (level 3). Data were analyzed using the XTMIXED
or XTREG multilevel random regression routine in Stata
11.0 (StataCorp, 2009). Effect sizes from predictors in
the multilevel model are expressed as B, representing
the unstandardized fixed regression coefficient.
Interactions were assessed by the Wald test. The size
of the moderator effects was calculated by applying
and testing the appropriate linear combinations using
the Stata MARGIN command. Raw cortisol values were
log transformed to reduce skewness of distribution,
generating the variable lncort. The variable time was
centered around the grand mean for all samples. To
model the cortisol diurnal curve, the variable time was
included as a predictor in all analyses with lncort
as the dependent variable ; addition of higher-order
polynomial terms did not improve the model fit.
Analyses were adjusted for the a priori selected con-
founders age, sex, intracranial volume and scan type.
In the patient group, the effect of AP use on HV size
was examined. Analyses were rerun including AP
(Meador-Woodruff & Greden, 1988; Mondelli et al.
2010a), antidepressant medication and history of de-
pression as covariates.
Group differences in HV, cortisol and stress reactivity
To test whether HV or mean cortisol level differed
between groups, a multilevel regression was
estimated with HV and lncort respectively as the de-
pendent variable and the categorical variable group
(0=controls, 1=siblings, 2=patients ; for cortisol, con-
trols and siblings only) as the independent variable,
taking into account that participants were nested
within families.
To test whether stress reactivity differed by group,
multilevel regression analyses were conducted with
event stress and group, and also their interaction term,
as independent variables and NA (and respectively
cortisol for controls and siblings) as the dependent
variable, again also controlling for familial clustering.
Interaction between group, stress reactivity and volume
To test whether HV was associated with emotional
stress reactivity, and whether this was moderated by
group, multilevel regression analyses were conducted
with event stress, HV (continuous variable) and group
(entered as a linear three-level variable of patients,
siblings and controls=reference), and also their inter-
action terms, as independent variables and NA as the
dependent variable :
NA=B0+B1 (group)+B2 (stress)+B3 (volume)
+B4 (grouprstress)+B5 (grouprvolume)
+B6 (stressrvolume)
+B7 (grouprstressrvolume):
For visualization purposes, HV was entered as the
dummy variable representing the distribution of vol-
ume calculated at the 50th percentiles of HV of the
controls : where 1 represents <50th percentile (small
HV) and 2 represents>50th percentile (large HV). To
ensure that definitions for small and large HV were
the same for all groups, patients and siblings were al-
located to hippocampal group on the basis of the cri-
teria for the control group (13 siblings and eight
patients in the large total HV group; 14 siblings and
six patients in the large left HV group; 12 siblings and
six patients in the large right HV group).
To test the hypothesis that controls and siblings
differed in their association between HV and cortisol
stress reactivity, the same model as described above
was applied to cortisol (lncort) as the dependent vari-
able. Additional confounders for all cortisol analyses
were : time of cortisol sample, estrogen exposure and
recent consumption of food or tobacco.
Results
Descriptive analyses
Groups were well matched on most demographic
variables (Table 1). Patients smoked more cigarettes
and cannabis than siblings and controls and had more
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lifetime hard drug use than siblings and controls, with
no significant differences between the latter two
groups. With regard to handedness, 9.4% of the con-
trols, 8.2% of the siblings and 20% of the patients were
left-handed (x22=2.01, p=0.37). All subjects were
Caucasian. Eighteen patients received AP (atypical :
n=2; typical : n=16). Furthermore, three patients used
an antidepressant and one patient used a benzodiaze-
pine. Six siblings and seven controls had a history of
major depressive disorder, but none presented in a
current depressive episode.
Two controls used an antidepressant and one con-
trol used a benzodiazepine. Patients reported higher
total, positive and negative PANSS scores than con-
trols and siblings, with no differences between the
latter two groups (Table 1). The mean duration of ill-
ness in the patient group was 6.15 years (S.D.=3.45).
There was no overall difference in saliva collection
times between the control and sibling group (B=0.15,
95% CIx0.27 to 0.56, p=0.49).
Group differences in HV, cortisol and stress
reactivity
There was a significant association between group and
HV. Patients (B=x247.6, 95% CI x415.1 to x80.01,
Table 1. Sample characteristics
Controls
(n=32)
Siblings
(n=37)
Patients
(n=20)
Test statistic+
p value
Age (years), mean (S.D.) 31.7 (11.4) 28.3 (7.8) 29.1 (8.0) F=1.38, p=0.24
Gender (male :female) 10 :22 14 :23 11 :09 x2=2.97, p=0.23
Completed education
(primary :secondary :university)a
0 : 11 :21 1 :14 :22 1 :15 :4 x2=12.0, p=0.02
PANSS score, mean (S.D.)
Positive scale 7.4 (1.3) 7.5 (1.1) 12.4 (5.1) F=28.89, p=0.00
Negative scale 8.0 (0.2) 8.2 (1.0) 10.8 (3.3) F=25.04, p=0.00
Disorganization scale 10.2 (0.4) 10.2 (0.5) 31.4 (4.1) F=23.55, p=0.00
Excitement scale 8.3 (0.6) 8.4 (1.1) 9.9 (2.1) F=14.11, p=0.00
Emotional distress scale 9.5 (2.5) 9.9 (2.3) 14.2 (5.0) F=20.57, p=0.00
Alcohol use present state, mean (S.D.) 6.1 (8.7) 7.6 (9.2) 4.9 (6.6) F=0.11, p=0.74
Cigarette use present state, mean (S.D.) 1.1 (3.9) 1.8 (4.6) 12.1 (11.9) F=23.50, p=0.00
Cannabis use, frequency
Past 12 months, mean (S.D.) 1.6 (8.8) 3.4 (12.6) 34.3 (99.8) F=4.79, p=0.03
Lifetime, mean (S.D.) 16.8 (34.4) 19.6 (35.7) 54.2 (48.0) F=0.00, p=0.00
Hard drug use, frequency
Past 12 months, mean (S.D.) 1.6 (9.2) 0.0 (0.0) 5.0 (18.2) F=0.89, p=0.4
Lifetime, mean (S.D.) 3.4 (13.0) 5.1 (15.4) 40.5 (73.05) F=8.66, p=0.01
Antipsychotics
Type of antipsychotic (typical : atypical) 2 : 16
Haloperidol equivalent present state, mean (S.D.) 2.4 (1.9)
Total antipsychotic use in haloperidol
equivalents, mean (S.D.)
48.2 (47.1)
Duration of illness (years), mean (S.D.) 6.2 (3.5)
Lifetime estrogen exposure, mean (S.D.) 17 589 (31 700) 18 474 (29 410) 672 (2013) F=2.84, p=0.10
Scan type (MDEFT v. MP-RAGE sequence)b 23 :09 26 :11 16 :04 x2=0.7, p=0.72
Hippocampal volume (mm3), mean (S.D.) 3669 (340) 3618 (384) 3491 (319) F=10.25, p=0.003
Cortisol (nmol/L), mean (S.D.) 2.65 (0.89) 3.63 (1.3) N.A. F=11.95, p=0.001
ESM observations, mean, n (S.D.) 44.19 (10.7) 40.68 (9.16) 42.05 (9.96) F=0.88, p=0.35
PANSS, Positive and Negative Syndrome Scale ; MDEFT, modified driven equilibrium Fourier transform; MP-RAGE,
magnetization prepared rapid acquisition gradient echo ; ESM, experience sampling method ; S.D., standard deviation ;
N.A., not available.
F/x2 and p values refer to between-group differences.
a Educational level was defined as the highest accomplished level of education (0=primary school, 1=secondary education,
2=university degree).
b Total proportion MP-RAGE scans balanced between the groups (around 1/3).
Hippocampal volume and momentary stress reactivity 5
p=0.01) and siblings (B=x148.6, 95% CI x292.66 to
x4.47, p=0.04) had smaller HV than controls. Patients
and siblings did not differ (B=99.0, 95% CIx57.63 to
255.61, p=0.22).
Siblings had significantly higher cortisol levels than
controls (B=0.28, 95% CI 0.11–0.45, p=0.001).
However, no significant association between cortisol
levels and total HV (B=x186.2, 95% CI x398.16 to
25.76, p=0.085), left HV (B=x157.1, 95% CIx393.72
to 79.62, p=0.19) or right HV (B=x215.4, 95% CI
x452.63 to 21.94, p=0.075) was found in the combined
group of siblings and controls and no significant in-
teraction between cortisol and group (siblings and con-
trols) was found for total HV (x21=0.00, p=0.99), left
HV (x21=0.03, p=0.85) or right HV (x21=0.03, p=0.86).
There was no significant group (patients, siblings,
controls)revent stress interaction in the model of NA
(x22=4.54, p=0.10) or, for siblings and controls, in the
model of cortisol (x21=0.03, p=0.87).
Emotional stress reactivity contingent on HV
and genetic risk
A significant grouprevent stressrtotal HV inter-
action was found in the model of NA (x22=6.54,
p=0.04). Differentiation by hemisphere revealed that
the interaction with left HV (x22=7.90, p=0.02) and
right HV (x22=6.76, p=0.03) was significant. Thus, the
association between total, left and right HV and stress
reactivity differed between groups (Fig. 1). Stratified
analyses revealed increased emotional stress reactivity
in controls with large HV in comparison to controls
with small HV, being only significant for total HV
(total : x21=3.93, p=0.048; left : x21=3.13, p=0.077;
right : x21=1.95, p=0.16). In siblings, small HV was
consistently associated with significantly more stress
reactivity than large HV (total : x21=6.89, p=0.009; left :
x21=6.20, p=0.013 ; right : x21=5.73, p=0.017). A similar
pattern was found in patients : small left HV was
associated with significantly more stress reactivity
than large left HV (left : x21=18.53, p<0.0001). No dif-
ference in stress reactivity was found for total and
right HV (total : x21=1.20, p=0.27 ; right : x21=0.06,
p=0.81).
Illness duration, AP use, antidepressant medication,
depression and handedness
Lifetime AP use did not predict HV in the patient
group (total : B=0.42, 95% CI x1.91 to 2.75, p=0.70 ;
left : B=1.69, 95% CI x0.83 to 4.21, p=0.17 ; right :
B=x0.85, 95% CI x3.18 to 1.48, p=0.45). Illness
duration did not predict HV in the patient group
(total : B=x35.48, 95% CIx75.98 to 5.01, p=0.08 ; left :
B=x40.92, 95% CI x86.54 to 4.70, p=0.08 ; right :
B=x30.04, 95% CI x72.16 to 2.08, p=0.15). More-
over, the results remained the same when handedness,
AP use, antidepressant use or history of depression
were entered as additional predictor to the analyses.
Cortisol stress reactivity contingent on HV and
genetic risk
There was a significant grouprevent stressrtotal HV
interaction in the model of cortisol (x21=5.74, p=0.017).
Differentiation by hemisphere revealed that the inter-
action was significant for left HV (x21=4.89, p=0.027)
and right HV (x21=3.89, p=0.049), suggesting that the
association between total, left and right HV and cor-
tisol reactivity to stress differed between the control
and sibling groups (Fig. 2). For the control group,
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Fig. 1. Emotional stress reactivity stratified by hippocampal volume (HV), in control, sibling and patient groups : multilevel
estimates of the effects of daily stress on momentary negative affect (NA). All interaction terms tested with the continuous HV
variable were significant. Stratification by small and large HV for visualization purposes. The models control for age, gender,
intracranial volume and scan type. Effects are unstandardized regression coefficients ; range of all standard errors was 0.02–0.04
(not depicted) (*** p<0.001, * p<0.05).
NA=b0+b1 (group)+b2 (stress)+b3 (HV)+b4 (grouprstress)+b5 (grouprHV)+b6 (stressrHV)+b7 (grouprstressrHV).
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stratified analyses revealed no significant differences
in cortisol response to daily stress between the hippo-
campal groups (total : x21=0.19, p=0.66 ; left : x21=0.71,
p=0.40 ; right : x21=0.00, p=0.95). In the sibling group,
however, small HV was associated with increased
cortisol responses to stress for the total and left HV
groups (total : x21=7.13, p=0.007 ; left : x21=7.38,
p=0.007 ; right : x21=0.89, p=0.35).
Discussion
To our knowledge, this is the first study to examine the
association between stress sensitivity and HV in a
sample with different levels of risk for psychosis. The
results show that the immediate effect of daily stress
on NA and cortisol was conditional not only on HV
but also on risk for psychosis. Patients with a small left
HV reported increased emotional stress reactivity
compared to patients with a large left HV. In line with
the results in patients, siblings with a small HV dem-
onstrated increased emotional and cortisol reactivity
to stress compared to those with a large HV. By
contrast, controls with a large total HV were more
emotionally stress reactive than controls with a small
total HV, although this was not the case for cortisol
reactivity.
HV and overall diurnal cortisol
In line with a substantial amount of (meta-analytic)
evidence (Wright et al. 2000; Vita et al. 2006), HV in
the patient group was smaller than that of the control
participants. Similarly, decreased HV in the siblings
of patients with a psychotic disorder was found,
which corresponds with findings from a meta-
analysis (Lawrie et al. 2008), as does the finding
of absence of differences in HV between patients
and their non-psychotic relatives (Seidman et al.
2002).
There was no association between overall diurnal
cortisol levels and HV, which is in line with a previous
study that found no association between HV and cor-
tisol in first-episode psychosis (Gunduz-Bruce et al.
2007). Another study, however, that differentiated be-
tween left and right HV, found that baseline cortisol
levels were associated with smaller left HV in first-
episode psychosis, but not in controls (Mondelli et al.
2010b). Although we investigated left and right HV
separately, no association between HV and overall
cortisol level was found in siblings and controls.
Nevertheless, there was a non-significant trend in the
direction of a negative association between HV and
overall diurnal cortisol levels, which is in line with the
result of Mondelli et al. (2010b) in first-episode psy-
chosis.
Stress reactivity and HV in patients with psychotic
disorder
In patients with a psychotic disorder, smaller left HV
was associated with increased emotional stress reac-
tivity whereas larger left HV was associated with a
diminished emotional response to stress. Thus, not
only were patients with a psychotic disorder more
likely to have a small hippocampus, but those with a
decreased left HV were also more likely to experience
augmented emotional stress reactivity. These findings
extend earlier findings of the importance of the left
hippocampus in the human stress response to the
realm of daily life stress reactivity (Liu et al. 2012).
Right HV, however, did not explain differences in
stress reactivity.
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Fig. 2.Cortisol stress reactivity stratified by hippocampal volume (HV), in sibling and control groups : multilevel estimates of the
effects of daily stress on cortisol. The dependent variable is log-transformed cortisol (lncort). All interaction terms tested with
the continuous HV variable were significant. Stratification by small and large HV for visualization purposes. The models control
for time, age, gender, oral estrogen exposure, recent food intake, recent smoking, intracranial volume and scan type. Effects are
unstandardized regression coefficients ; range of all standard errors was 0.04–0.07 (not depicted) (** p<0.01).
lncort=b0+b1 (group)+b2 (stress)+b3 (HV)+b4 (grouprstress)+b5 (grouprHV)+b6 (stressrHV)+b7 (grouprstressrHV).
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We found differences in stress reactivity within the
group of patients with psychotic disorder that could
be traced to differences in left HV; that is, patients
with a smaller left HV were most responsive to the
environment. This finding underscores the notion that
there might be different pathways to psychotic dis-
order, the stress-related pathway being one of them
(Myin-Germeys & van Os, 2007 ; Lataster et al. 2010).
For example, patients with a smaller HV may have
experienced childhood trauma, impacting on cumu-
lative glucocorticoid exposure and HV. Childhood
trauma has been associated with reductions in adult
HV, particularly on the left side (Stein et al. 1997).
Hereby, several hippocampal subfields are impacted
by childhood trauma and adversities (Teicher et al.
2012). Another line of evidence underlines the im-
portance of severe pregnancy and birth complications
in making a significant contribution to hippocampal
abnormalities in schizophrenia (Stefanis et al. 1999),
particularly the left hippocampus, emphasizing the
importance of non-genetic factors on HV reduction
(Schulze et al. 2003). The HV, in turn, as shown
in the current study, may regulate subtle everyday
life stress responses. However, it is important to
note that the direction of the association between HV
and daily life stress reactivity is unresolved. The
question of whether early acquired heightened cortisol
reactivity may ultimately cause HV changes or
whether alterations in HV, for instance acquired pre-
natally, are responsible for increased everyday
stress reactivity should be answered in longitudinal
studies.
Stress reactivity and HV in subjects at familial risk
for psychotic disorder
Similar to the findings in patients, siblings with
smaller HV exhibited increased emotional and cortisol
stress reactivity whereas larger HV in the siblings was
associated with decreased emotional and cortisol
responses to stress. These findings suggest that the
association between smaller HV and increased stress
reactivity may be a trait marker for psychotic disorder.
With respect to the related mechanisms, Buchanan
et al. (2009) suggested that the hippocampus may be a
crucial element of a network involved in producing an
integrated response to psychosocial stress (indexed by
behavior and HPA axis activity). Earlier ESM work
suggests that an association between cortisol reactivity
and negative emotions might be particularly present
in those with an increased familial risk for psychotic
disorders (Collip et al. 2011). In the current study, we
found an increased emotional and cortisol response to
stress in siblings with smaller HV and, in patients, a
smaller left HV was also associated with increased
emotional response to stress. It may be that these as-
sociations represent markers for reduced integration
of the stress response in those with psychotic
disorder or at familial risk for psychosis. In other
words, the combination of a decreased stress response
and larger HV in the siblings, in addition to the
increased stress responses in those with smaller HV,
may reflect suboptimal HPA axis functioning. This
may be a sign of a suboptimal response to psycho-
social stress, resulting in increased liability for psy-
chosis. However, another possibility is that the
blunted cortisol stress response in siblings with a lar-
ger HV represents a protective factor against
illness expression, given increased background vul-
nerability.
Stress reactivity and HV in healthy controls
In controls, we found no association between left and
right HV and stress reactivity. However, for total HV
the reverse pattern was present, with smaller total
HV associated with reduced emotional stress reac-
tivity, and larger total HV associated with increased
emotional stress reactivity. Cortisol reactivity to small
daily hassles, however, did not differ as a function of
HV in the control group.
These findings contradict another study in healthy
adults that reported evidence for an association be-
tween stress level and smaller anterior HV (Szeszko
et al. 2006). However, the stress measure used com-
prised retrospective summary information. By con-
trast, the current study measures emotional stress
reactivity in daily life. Our findings at the emotional
level do correspond with a study by Pruessner et al.
(2007), who found that a larger HV in healthy young
participants was associated with increased cortisol
response to awakening (CAR) and to an experimental
stressor. Pruessner et al. (2007) speculated that a larger
hippocampus may require increased cortisol con-
centrations for optimal functioning. However, we
found no association between HV and cortisol stress
reactivity in the control group. Differences in cortisol
measures between the current study and the study by
Pruessner et al. (2007) may constitute one explanation
for the discrepant findings. Cortisol responses to lab-
oratory stress and to awakening may affect different
aspects of HPA axis reactivity than the reactivity to
everyday hassles, which are probably more subtle
stimuli. Nevertheless, the control participants with
larger HV reported elevated emotional stress reac-
tivity to naturally occurring stressors compared to
those with smaller HV, which corresponds to the cor-
tisol reactivity findings reported by Pruessner et al.
(2007) and indeed might reflect healthy functioning of
the stress system.
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Strength and weaknesses
This study has several limitations. First, the use of
ESM booklets instead of electronic devices means that
the exact timing of participants’ self-reports and saliva
samples cannot be firmly established (Stone et al.
2002). However, the results of a study comparing self-
reported and electronically monitored saliva collection
times, with the same intensive, semi-random time-
sampling protocol used in the current study, indicated
that saliva was generally collected very close to the
prescribed time and that self-reported collection times
corresponded well with the electronic time-stamps
(Jacobs et al. 2005). Another comparative study con-
cluded that paper and electronic diaries yield similar
results (Green et al. 2006).
Second, the current study used a daily life assess-
ment technique in which participants had to comply
with a paper-and-pencil diary protocol without the
researcher being present, making it difficult to deter-
mine whether patients interpreted the ESM questions
about, for instance, stress similarly to the other two
groups. However, many ESM studies have shown
meaningful associations also in groups of patients
with psychotic disorders, suggesting that it is feasible
for patients with psychotic disorders to participate
in daily life research and to properly fill out ques-
tionnaires on a momentary basis (Oorschot et al.
2009). Third, cortisol stress reactivity was not exam-
ined in the patients, as no saliva samples were
collected for the patient group (because of the study
design and concern about illness and treatment effects
on cortisol). Future studies should include cortisol
measures in patients with a psychotic disorder, to ex-
plore associations between daily life cortisol stress re-
activity and HV in patients. Fourth, no saliva samples
were taken at the time of awakening, so that the cur-
rent dataset does not allow examination of the CAR, a
measure of HPA axis activity that seems to be blunted
in first-episode psychosis (Mondelli et al. 2010a) and
may be associated with HV (Pruessner et al. 2007).
Another issues is the use of HV, as volume is not
necessarily an indicator of hippocampal functioning.
However, it should be underlined that this is the first
study of its kind (combining brain imaging with mo-
mentary daily life measures). Future studies should
examine these associations in more detail by including
functional imaging.
The current study also has some specific strengths.
In particular, the repeated sampling of salivary cor-
tisol over 6 days takes into account the well-known
but often ignored unreliability of cortisol measures
obtained at infrequent intervals (Hruschka et al. 2005).
Multiple cortisol measures per person were comple-
mented by a relatively large number of participants.
Use of multilevel modeling allowed assessment of
within-person associations between cortisol and sub-
jective experience in real time and real-life contexts, as
moderated by the HV. Although cortisol measures
were within the normal range, intensive sampling re-
vealed different patterns of HPA axis activity with
different HVs. Moreover, we combined measures of
emotional and cortisol stress sensitivity with HV size,
allowing a more comprehensive examination of HPA
axis functioning.
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